|
Volumn 23, Issue 2, 1996, Pages 204-206
|
Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography
a a a a a a |
Author keywords
Fluorodeoxyglucose; Lung neoplasm; Positron emission tomography
|
Indexed keywords
FLUORODEOXYGLUCOSE F 18;
RADIOPHARMACEUTICAL AGENT;
ABDOMEN;
ADULT;
AGED;
ARTICLE;
BONE SCINTISCANNING;
CANCER CELL;
CANCER STAGING;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC IMAGING;
DIFFERENTIAL DIAGNOSIS;
FEMALE;
HUMAN;
INTERMETHOD COMPARISON;
LUNG NON SMALL CELL CANCER;
MAJOR CLINICAL STUDY;
MALE;
METASTASIS;
POSITRON EMISSION TOMOGRAPHY;
THORAX;
TUMOR BIOPSY;
AGED;
BONE AND BONES;
CARCINOMA, NON-SMALL-CELL LUNG;
DEOXYGLUCOSE;
FALSE POSITIVE REACTIONS;
FEMALE;
FLUORINE RADIOISOTOPES;
FLUORODEOXYGLUCOSE F18;
HUMANS;
LUNG NEOPLASMS;
MALE;
NEOPLASM STAGING;
PROSPECTIVE STUDIES;
TOMOGRAPHY, EMISSION-COMPUTED;
TOMOGRAPHY, X-RAY COMPUTED;
|
EID: 0030023768
PISSN: 03406997
EISSN: None
Source Type: Journal
DOI: 10.1007/BF01731846 Document Type: Article |
Times cited : (76)
|
References (12)
|